MREO
Price
$0.37
Change
-$0.02 (-5.13%)
Updated
Feb 13 closing price
Capitalization
59.18M
45 days until earnings call
Intraday BUY SELL Signals
NNVC
Price
$1.00
Change
+$0.07 (+7.53%)
Updated
Feb 13 closing price
Capitalization
21.57M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MREO vs NNVC

Header iconMREO vs NNVC Comparison
Open Charts MREO vs NNVCBanner chart's image
Mereo BioPharma Group
Price$0.37
Change-$0.02 (-5.13%)
Volume$1.88M
Capitalization59.18M
NanoViricides
Price$1.00
Change+$0.07 (+7.53%)
Volume$226.23K
Capitalization21.57M
MREO vs NNVC Comparison Chart in %
MREO
Daily Signal:
Gain/Loss:
NNVC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MREO vs. NNVC commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a StrongBuy and NNVC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (MREO: $0.37 vs. NNVC: $1.00)
Brand notoriety: MREO and NNVC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 10% vs. NNVC: 78%
Market capitalization -- MREO: $59.49M vs. NNVC: $21.57M
MREO [@Biotechnology] is valued at $59.49M. NNVC’s [@Biotechnology] market capitalization is $21.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green whileNNVC’s FA Score has 1 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • NNVC’s FA Score: 1 green, 4 red.
According to our system of comparison, MREO is a better buy in the long-term than NNVC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 3 TA indicator(s) are bullish while NNVC’s TA Score has 6 bullish TA indicator(s).

  • MREO’s TA Score: 3 bullish, 2 bearish.
  • NNVC’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, NNVC is a better buy in the short-term than MREO.

Price Growth

MREO (@Biotechnology) experienced а -12.39% price change this week, while NNVC (@Biotechnology) price change was +13.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

MREO is expected to report earnings on Apr 01, 2026.

NNVC is expected to report earnings on Feb 16, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($59.2M) has a higher market cap than NNVC($21.6M). MREO YTD gains are higher at: -10.751 vs. NNVC (-11.504). NNVC has higher annual earnings (EBITDA): -7.41M vs. MREO (-40.14M). MREO has more cash in the bank: 48.7M vs. NNVC (1.13M). MREO has less debt than NNVC: MREO (397K) vs NNVC (1.5M). MREO has higher revenues than NNVC: MREO (500K) vs NNVC (0).
MREONNVCMREO / NNVC
Capitalization59.2M21.6M274%
EBITDA-40.14M-7.41M541%
Gain YTD-10.751-11.50493%
P/E RatioN/AN/A-
Revenue500K0-
Total Cash48.7M1.13M4,325%
Total Debt397K1.5M26%
FUNDAMENTALS RATINGS
MREO vs NNVC: Fundamental Ratings
MREO
NNVC
OUTLOOK RATING
1..100
584
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9788
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NNVC's Valuation (28) in the Biotechnology industry is in the same range as MREO (59) in the null industry. This means that NNVC’s stock grew similarly to MREO’s over the last 12 months.

NNVC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MREO (100) in the null industry. This means that NNVC’s stock grew similarly to MREO’s over the last 12 months.

NNVC's SMR Rating (98) in the Biotechnology industry is in the same range as MREO (98) in the null industry. This means that NNVC’s stock grew similarly to MREO’s over the last 12 months.

NNVC's Price Growth Rating (88) in the Biotechnology industry is in the same range as MREO (97) in the null industry. This means that NNVC’s stock grew similarly to MREO’s over the last 12 months.

MREO's P/E Growth Rating (1) in the null industry is significantly better than the same rating for NNVC (100) in the Biotechnology industry. This means that MREO’s stock grew significantly faster than NNVC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MREONNVC
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
MREO
Daily Signal:
Gain/Loss:
NNVC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DFIN39.120.71
+1.85%
Donnelley Financial Solutions
RSG223.172.30
+1.04%
Republic Services
SNDR28.730.16
+0.56%
Schneider National
OBIO3.830.01
+0.26%
Orchestra BioMed Holdings
MOBX0.19N/A
-0.10%
Mobix Labs

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been closely correlated with ARTV. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MREO jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-4.32%
ARTV - MREO
89%
Closely correlated
+0.25%
VTGN - MREO
87%
Closely correlated
-7.23%
TPST - MREO
84%
Closely correlated
+2.16%
RZLT - MREO
81%
Closely correlated
+5.79%
LENZ - MREO
81%
Closely correlated
-0.69%
More

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with LEGN. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then LEGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+7.53%
LEGN - NNVC
54%
Loosely correlated
-2.66%
TPST - NNVC
51%
Loosely correlated
+2.16%
CUE - NNVC
50%
Loosely correlated
+2.20%
ARCT - NNVC
49%
Loosely correlated
+0.56%
MREO - NNVC
48%
Loosely correlated
-4.32%
More